Imperial College London
Portrait Picture

PROFESSOR NICHOLAS LONG

Faculty of Natural Sciences, Department of Chemistry

Sir Edward Frankland BP Chair -Inorganic Chemistry
 
 
 
//

Contact

 

+44 (0)20 7594 5781n.long Website CV

 
 
//

Location

 

501jMolecular Sciences Research HubWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Jiang:2019:10.1073/pnas.1915372116,
author = {Jiang, L and Lung, HL and Huang, T and Lan, R and Zha, S and Chan, LS and Thor, W and Tsoi, T and Chau, H and Boreström, C and Cobb, S and Tsao, SW and Bian, Z and Law, G and Wong, W and Tai, WC and Chau, YW and Du, Y and Tang, LHX and Chiang, AKS and Middeldorp, JM and Lo, K and Mak, N and Long, N and Wong, K},
doi = {10.1073/pnas.1915372116},
journal = {Proceedings of the National Academy of Sciences of USA},
pages = {26614--26624},
title = {Reactivation of Epstein Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function.},
url = {http://dx.doi.org/10.1073/pnas.1915372116},
volume = {116},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Epstein-Barr nuclear antigen 1 (EBNA1) plays a vital role in the maintenance of the viral genome, and is the only viral protein expressed in nearly all forms of EBV latency and EBV-associated diseases including numerous cancer types. To our knowledge, no specific agent against Epstein Barr virus (EBV) genes or proteins has been established to target EBV lytic reactivation. Here we report an EBNA1- and Zn2+- responsive probe (ZRL5P4), which alone could reactivate EBV lytic cycle through specific disruption of EBNA1. We have utilized the Zn2+ chelator to further interfere with the higher order of EBNA1 self-association. The new bioprobe ZRL5P4 can respond independently to its interactions with Zn2+ and EBNA1 with different fluorescence changes. It can selectively enter the nuclei of EBV-positive cells and disrupt the oligomerization and oriP-enhanced transactivation of EBNA1. ZRL5P4 can also specifically enhance Dicer1 and PML expression, molecular events which had been reported to occur after the depletion of EBNA1 expression. Importantly, we found that the treatment with ZRL5P4-alone could reactivate the EBV lytic induction by expressing the early and late EBV lytic genes/proteins. The lytic induction is likely mediated by disruption of EBNA1 oligomerization and the subsequent change of Dicer1 expression. Our new probe ZRL5P4 represents the first EBV protein-specific agent to potently reactivate EBV from latency, leading to the shrinkage of EBV-positive tumours, and our study also suggests the association of EBNA1 oligomerization with the maintenance of EBV latency.
AU  - Jiang,L
AU  - Lung,HL
AU  - Huang,T
AU  - Lan,R
AU  - Zha,S
AU  - Chan,LS
AU  - Thor,W
AU  - Tsoi,T
AU  - Chau,H
AU  - Boreström,C
AU  - Cobb,S
AU  - Tsao,SW
AU  - Bian,Z
AU  - Law,G
AU  - Wong,W
AU  - Tai,WC
AU  - Chau,YW
AU  - Du,Y
AU  - Tang,LHX
AU  - Chiang,AKS
AU  - Middeldorp,JM
AU  - Lo,K
AU  - Mak,N
AU  - Long,N
AU  - Wong,K
DO  - 10.1073/pnas.1915372116
EP  - 26624
PY  - 2019///
SN  - 0027-8424
SP  - 26614
TI  - Reactivation of Epstein Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function.
T2  - Proceedings of the National Academy of Sciences of USA
UR  - http://dx.doi.org/10.1073/pnas.1915372116
UR  - https://www.pnas.org/content/116/52/26614
UR  - http://hdl.handle.net/10044/1/75250
VL  - 116
ER  -
Download